Literature DB >> 11914603

Prognostic significance of the thymidylate biosynthetic enzymes in human colorectal tumors.

Judit Kralovánszky1, István Köves, Zolst Orosz, Csilla Katona, Katalin Tóth, Pál Rahóty, Ferenc Czeglédi, Tibor Kovács, Barna Budai, Lehel Hullán, András Jeney.   

Abstract

The aim of the present study was to determine the relative intratumoral activity of two pyrimidine biosynthetic enzymes, i.e. thymidylate synthase (TS) and thymidine kinase (TK), in human colorectal cancers to compare their possible relationship with demographic and pathologic characteristics of the patients and their tumors, and moreover to evaluate their predictive significance regarding 5-fluorouracil (5-FU) sensitivity and the overall survival of patients, respectively. TS and TK levels were significantly increased in the tumor compared to peritumoral tissue. However, no significant relationship between TS/TK activity and demographic features of the patients or pathologic characteristics of their tumors could be demonstrated. Kaplan-Meier analysis showed that the overall survival of patients with low TS activity was significantly longer (p < 0.012) compared to those with high TS activity. Such a difference could not be demonstrated between patients with high or low TK activity; however, combined evaluation of the two parameters proved that TK may contribute to the more precise assessment of disease prognosis, and it may further influence treatment decisions, i.e. the selection of patients for adjuvant therapy with 5-FU and folinic acid. Multivariate analysis showed that among the variables tested, beside Dukes' stage, TS and TK activities were significant prognostic factors for the overall survival of colorectal cancer patients. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11914603     DOI: 10.1159/000048263

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  2 in total

1.  Polymorphism of thymidylate synthase gene associated with its protein expression in human colon cancer.

Authors:  Kai-Huan Yu; Wei-Xing Wang; You-Ming Ding; Hui Li; Ze-Sheng Wang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

2.  Thymidylate synthase gene polymorphism and survival of colorectal cancer patients receiving adjuvant 5-fluorouracil.

Authors:  Violetta Sulzyc-Bielicka; Dariusz Bielicki; Agnieszka Binczak-Kuleta; Mariusz Kaczmarczyk; Wiesława Pioch; Anna Machoy-Mokrzynska; Andrzej Ciechanowicz; Magdalena Gołębiewska; Marek Drozdzik
Journal:  Genet Test Mol Biomarkers       Date:  2013-08-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.